The Effect of Sensory Level Versus Motor Level Electrical Stimulation of Pharyngeal Muscles in Acute Stroke Patients With Dysphagia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Stroke, Ischemic
- Sponsor
- Casa Colina Hospital and Centers for Healthcare
- Enrollment
- 31
- Locations
- 1
- Primary Endpoint
- Change in Dysphagia outcome Severity Scale
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
Dysphagia is a serious cause of morbidity and mortality in stroke survivors. Electrical stimulation is often included as part of the treatment plan for dysphagia, and can be applied at a sensory or motor level intensity. However, evidence to support these different modes of stimulation is lacking. This study compared the effectiveness of sensory and motor level stimulation on post-stroke dysphagia.
Detailed Description
Objective: Dysphagia is a serious cause of morbidity and mortality in stroke survivors. Electrical stimulation is often included as part of the treatment plan for dysphagia, and can be applied at a sensory or motor level intensity. However, evidence to support sensory versus motor stimulation is lacking. This study compares the effect of sensory and motor stimulation on post-stroke dysphagia. Design: Randomized controlled trial Setting: Inpatient rehabilitation facility. Participants: Participants (50-75 years of age) who had dysphagia caused by a stroke within 6 months prior to enrollment were included. Participants were excluded if they had a contraindication for electrical stimulation, previous stroke, psychiatric disorder, contraindications for MBS, or pre-stroke swallowing disorders. Interventions: Each patient received ten, 45-minute anterior neck sensory or motor level electrical stimulation sessions in addition to standard speech therapy. Motor stimulation was administered as a stimulus intensity sufficient to produce muscle contractions. Sensory stimulation was defined as the threshold when the patient feels a tingling sensation on their skin (approximately 4-5mA). Main Outcome Measures: Swallow FIM, National Outcome Measurement System (NOMS), Dysphagia Outcome Severity Scale (DOSS), and change in modified diet.
Investigators
Emily Rosario
Director of Research
Casa Colina Hospital and Centers for Healthcare
Eligibility Criteria
Inclusion Criteria
- •acute ischemic CVA within the first month and confirmed by MRI.
- •Diagnosis of dysphagia will be obtained by bedside swallowing exam and MBS/FEES studies.
Exclusion Criteria
- •patients who have contraindications for electrical stimulation (malignancy, DVT/thrombophlebitis, hemorrhagic conditions, pregnancy, pacemaker or other electrical hardware)
- •known premorbid swallowing disorders
- •dementia or psychiatric disorder
- •bilateral cerebral involvement
- •contraindications for FEES/MBS (infectious disease such as HIV, HCV, HBV, nasal obstruction, decompensated heart disease, risk of bleeding such as active ulcers, allergy to contrast).
Outcomes
Primary Outcomes
Change in Dysphagia outcome Severity Scale
Time Frame: up to 2 months
seven-point functional outcome scale designed to assess dysphagia severity on the MBSS, lowest score = 1; highest = 7.
Change in Swallow Functional Assessment Measure
Time Frame: up to 2 months
7 point swallow scale the Functional oral intake scale (FOIS) lowest score = 1; highest = 7.
Secondary Outcomes
- Change in Swal-Qol(up to 3 months)
- Change in PenAsp(up to 2 months)